MMWR Recommendations and Reports

MMWR Recommendations and Reports is a peer-reviewed serial publication of the Morbidity and Mortality Weekly Report (MMWR) series issued by the U.S. Centers for Disease Control and Prevention (CDC), founded in 1989, and it carries in-depth policy statements for prevention and treatment across the whole scope of CDC's responsibilities, with a 2025 Journal Impact Factor of 51.3（MMWR Recommendations and Reports）是美国疾病控制与预防中心（CDC）出版的《发病率和死亡率周报》（MMWR）系列中的同行评审专刊，1989 年创办，刊载覆盖 CDC 全部职责范围的预防与治疗深度政策声明，2025 年影响因子为 51.3。

Scope

• The journal contains in-depth articles that relay policy statements for prevention and treatment on all areas in CDC's scope of responsibility该刊刊载传递 CDC 全部职责范围内预防与治疗政策声明的深度文章。
• It is a principal outlet for recommendations from the Advisory Committee on Immunization Practices, including the annual influenza and routine immunization schedules它是免疫实践咨询委员会建议的主要发布渠道，包括年度流感与常规免疫程序。^[1]
• It publishes evidence-based guidance on topics such as opioid prescribing, screening and testing for infectious diseases, and post-exposure prophylaxis它发布关于阿片类药物处方、传染病筛查与检测、暴露后预防等主题的循证指南。
• Reports typically consolidate and grade the evidence behind each recommendation报告通常整合并对各项推荐背后的证据进行分级。
• It is written for clinicians, public health officials, epidemiologists and policymakers读者对象为临床医生、公共卫生官员、流行病学家与政策制定者。
• It is one of the four regular MMWR publications, alongside MMWR Weekly, MMWR Surveillance Summaries and MMWR Supplements它与《MMWR 周报》《MMWR 监测摘要》《MMWR 增刊》并列，为 MMWR 系列的四种常规出版物之一。
• All content is freely available online in the public domain, with no subscription fee and no author publication charge全部内容以公有领域形式免费在线获取，既无订阅费，也无作者发表费。

History

• The Recommendations and Reports series began on 26 January 1989 as volume 39, number RR-1, when CDC created a dedicated serial for its policy statements建议与报告专刊于 1989 年 1 月 26 日以第 39 卷 RR-1 期创刊，CDC 由此为其政策声明设立专门专刊。
• The parent MMWR series grew out of weekly morbidity statistics first published by the National Office of Vital Statistics in 1952, and CDC began publishing MMWR on 13 January 1961其母刊 MMWR 源自 1952 年美国国家生命统计办公室首次发布的每周疾病统计，CDC 于 1961 年 1 月 13 日开始出版 MMWR。
• Before the series existed, recommendations were carried in the weekly report, and separate publication allowed longer and more detailed guidance在该专刊出现之前，建议刊于周报，分立出版使指南得以更完整详尽。
• The journal appears irregularly, and each issue has its own distinctive title and can run to dozens of pages该刊不定期出版，每期均有独立标题，篇幅可长达数十页。
• It is prepared in-house by CDC, and all its material is in the public domain and may be reused and reprinted without special permission该刊由 CDC 自行制作，其全部材料属公有领域，可不经特别许可使用与转载。
• Its Journal Impact Factor moved from 60.1 in 2024 to 51.3 in 2025, when it ranked second among 443 journals in the category of Public, Environmental and Occupational Health其影响因子由 2024 年的 60.1 变为 2025 年的 51.3，并在公共卫生、环境与职业卫生类别的 443 种期刊中位列第二。

Editors

• The MMWR series is prepared by CDC's own editorial and production staff rather than an external commercial publisher, and it is known as the voice of CDCMMWR 系列由 CDC 自己的编辑与制作团队而非外部商业出版社制作，被誉为「CDC 之声」。
• The series is led by an editor-in-chief, and Leonard Jack, Jr. has served as acting editor-in-chief of the MMWR series since January 2026 while remaining editor-in-chief of Preventing Chronic Disease该系列由一位主编领导，Leonard Jack Jr. 自 2026 年 1 月起担任 MMWR 系列的代理主编，同时仍任（Preventing Chronic Disease）主编。
• The serial publications, namely Recommendations and Reports, Surveillance Summaries and Supplements, are handled by the MMWR serial publications team, with Terisa F. Rutledge serving as managing editor since 2008各专刊，即建议与报告、监测摘要与增刊，由 MMWR 专刊团队负责，Terisa F. Rutledge 自 2008 年起任执行编辑。
• Manuscripts are submitted through CDC's ScholarOne system, which has a separate portal for serial publications, and are assessed under MMWR editorial policies稿件经 CDC 的 ScholarOne 系统提交，该系统为专刊另设入口，并依 MMWR 编辑政策评审。
• Recommendations from the Advisory Committee on Immunization Practices are drafted by CDC working groups and reviewed by the committee before publication免疫实践咨询委员会的建议由 CDC 工作组起草，经委员会审议后方予发表。
• There are no author publication charges, and readers may reuse content without special permission because it lies in the public domain该刊不收取作者发表费，因内容属公有领域，读者可不经特别许可重复使用。